BTIG Sticks to Its Buy Rating for DHT Holdings (DHT)
BTIG analyst Gregory Lewis maintained a Buy rating on DHT Holdings (DHT – Research Report) yesterday and set a price target of $16.00. The ...
Agios Pharma (AGIO) Receives a Buy from RBC Capital
In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Agios Pharma (AGIO – Research Report), with a price ...